+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
MRI Guided Neurosurgical Ablation Market - Global Forecast 2026-2032- Product Image
MRI Guided Neurosurgical Ablation Market - Global Forecast 2026-2032- Product Image
New

MRI Guided Neurosurgical Ablation Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 181 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968798
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The MRI guided neurosurgical ablation market is undergoing rapid transformation as advanced imaging technologies and innovative energy delivery systems redefine surgical standards in neuro-oncology and neuromodulation. Senior decision-makers must stay attuned to evolving adoption trends and operational best practices that influence market positioning and long-term growth strategies.

Market Snapshot: MRI Guided Neurosurgical Ablation Market Overview

The MRI guided neurosurgical ablation market is experiencing steady expansion, rising from USD 708.88 million in 2025 to USD 763.35 million in 2026, with expectations to reach USD 1.41 billion by 2032, at a CAGR of 10.35%. Growth reflects investments in high-resolution imaging and minimally invasive treatment approaches, supported by evolving healthcare investment priorities. Integration of MRI guidance into ablation therapy delivery is driving broader application to complex neurological diseases, establishing a resilient foundation for continual sector advancement.

Scope & Segmentation

  • Device Types: The market includes Focused Ultrasound systems, both high and low intensity, Laser Ablation technologies using diode and fiber laser configurations, and Radiofrequency Ablation units available in bipolar and monopolar modalities. These devices are engineered to address diverse procedural requirements within neurotherapeutic environments.
  • Thermal Technologies: High-Intensity Focused Ultrasound (HIFU) and Laser Interstitial Thermal Therapy (LITT) play central roles in delivering targeted, controlled therapies tailored to clinical and operational variation in care settings.
  • Clinical Applications: Technologies in this sector enable precise interventions for a wide range of disorders, spanning brain tumors such as glioblastoma, meningioma, and metastatic lesions, extending to pain management for conditions like sciatica and trigeminal neuralgia, and further to epilepsy and movement disorders such as dystonia, essential tremor, and Parkinson’s disease.
  • End User Settings: Devices are deployed within ambulatory surgical centers, hospitals, and research institutes, each setting requiring tailored solutions to optimize procedural workflow, clinician training, and patient care outcomes.
  • Regions Covered: Market analysis includes the Americas, Europe Middle East & Africa, and Asia-Pacific, accounting for regional variations in clinical practice, infrastructure readiness, and adoption patterns within the global neurotherapeutics landscape.

Key Takeaways: Strategic Insights for Decision-Makers

  • The integration of MRI-based thermometry with energy delivery technologies improves intraoperative control, empowering clinical teams to target therapies with greater precision across evolving procedural spectra.
  • Collaborations between multidisciplinary care teams and streamlined referral systems are accelerating routine adoption of ablation therapies and enhancing operational efficiency for healthcare providers.
  • Device engineering trends prioritize modularity and MRI compatibility to simplify setup, shorten clinician onboarding, and foster broader access within diverse institutional settings.
  • Regulatory shifts and increased real-world clinical validation are enhancing payer and provider confidence, supporting favorable reimbursement paths and facilitating technology uptake.
  • Market penetration and adoption rates are defined by leadership commitment, financial planning, and region-specific infrastructure, driving unique timelines for ecosystem development.
  • Securing competitive advantages depends on demonstrating strong clinical outcomes, adopting flexible supply chain strategies, and building robust partnerships that ensure reliable technology adoption and support services.

Tariff Impact: How 2025 Measures Reshaped Value Chains

The 2025 tariff adjustments in the United States imposed both cost pressures and supply constraints, compelling manufacturers to diversify suppliers and shift to modular assembly near key markets. Healthcare facilities responded by selecting equipment with adaptable sourcing options and adjusting procurement timelines. Supply chain partners sharpened inventory accuracy and compliance practices, while investors now demand explicit risk-management strategies before market expansion. These adaptations collectively reinforce device supply stability and maintain service capability amidst regulatory changes.

Methodology & Data Sources

This report utilizes a robust mixed-methods approach, including direct clinician interviews, systematic reviews of scientific literature, regulatory landscape assessments, and supplier ecosystem analysis. Independent triangulation and structured validation processes support data integrity, ensuring insights are actionable for executive planning.

MRI Guided Neurosurgical Ablation Market: Why This Report Matters

  • Enables leaders to identify and manage operational and regulatory risks when introducing advanced neurosurgical ablation therapies within clinical practice.
  • Equips decision-makers with insights for investment and sourcing by mapping market segments and regional attributes to changing care delivery models.
  • Offers in-depth analysis to strengthen strategic leadership and cultivate resilience in both clinical and business models as MRI-guided ablation becomes standard therapy.

Conclusion

As advanced imaging platforms, device innovation, and integrated care models converge, the MRI guided neurosurgical ablation market presents new opportunities for surgical precision and business growth. This report serves as a vital resource for leadership seeking to align with evolving sector drivers and market requirements.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. MRI Guided Neurosurgical Ablation Market, by Type
8.1. Focused Ultrasound
8.1.1. High Intensity
8.1.2. Low Intensity
8.2. Laser Ablation
8.2.1. Diode Laser
8.2.2. Fiber Laser
8.3. Radiofrequency Ablation
8.3.1. Bipolar
8.3.2. Monopolar
9. MRI Guided Neurosurgical Ablation Market, by Technology
9.1. High-Intensity Focused Ultrasound (HIFU)
9.2. Laser Interstitial Thermal Therapy (LITT)
10. MRI Guided Neurosurgical Ablation Market, by Application
10.1. Brain Tumors
10.1.1. Glioblastoma
10.1.2. Meningioma
10.1.3. Metastatic Tumors
10.2. Chronic Pain
10.2.1. Sciatica
10.2.2. Trigeminal Neuralgia
10.3. Epilepsy
10.3.1. Focal Epilepsy
10.3.2. Temporal Lobe Epilepsy
10.4. Movement Disorders
10.4.1. Dystonia
10.4.2. Essential Tremor
10.4.3. Parkinson’s Disease
11. MRI Guided Neurosurgical Ablation Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
11.3. Research Institutes
12. MRI Guided Neurosurgical Ablation Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. MRI Guided Neurosurgical Ablation Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. MRI Guided Neurosurgical Ablation Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States MRI Guided Neurosurgical Ablation Market
16. China MRI Guided Neurosurgical Ablation Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Boston Scientific Corporation
17.6. Brown Neurosurgery
17.7. ClearPoint Neuro, Inc.
17.8. Cook Group Incorporated
17.9. Ginger Healthcare Private Ltd.
17.10. HCA International Limited
17.11. INSIGHTEC Ltd
17.12. Medtronic plc
17.13. Monteris Medical Corporation
17.14. Seattle Children’s Hospital
17.15. Siemens Healthineers AG
17.16. SternMed GmbH
List of Figures
FIGURE 1. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HIGH INTENSITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HIGH INTENSITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HIGH INTENSITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LOW INTENSITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LOW INTENSITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LOW INTENSITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DIODE LASER, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DIODE LASER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DIODE LASER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FIBER LASER, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FIBER LASER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FIBER LASER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BIPOLAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BIPOLAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BIPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MONOPOLAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MONOPOLAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MONOPOLAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL THERAPY (LITT), BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL THERAPY (LITT), BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL THERAPY (LITT), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GLIOBLASTOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GLIOBLASTOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MENINGIOMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MENINGIOMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY METASTATIC TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY METASTATIC TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY METASTATIC TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY SCIATICA, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY SCIATICA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY SCIATICA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCAL EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCAL EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCAL EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TEMPORAL LOBE EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TEMPORAL LOBE EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TEMPORAL LOBE EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DYSTONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DYSTONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ESSENTIAL TREMOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ESSENTIAL TREMOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PARKINSON’S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PARKINSON’S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 149. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 155. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 170. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 173. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 174. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 178. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 179. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 180. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 198. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 199. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 200. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 201. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 203. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 204. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 206. ASEAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 209. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 210. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 211. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 212. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 213. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 215. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 216. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 217. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 218. GCC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 233. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 234. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 235. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 236. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 238. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 239. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 240. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 241. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 242. BRICS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 245. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 246. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 247. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 248. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 250. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 251. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 252. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 253. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 254. G7 MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 257. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 258. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 259. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 260. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 263. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 264. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 265. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 266. NATO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 282. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2032 (USD MILLION)
TABLE 283. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2032 (USD MILLION)
TABLE 284. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2032 (USD MILLION)
TABLE 285. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 286. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2032 (USD MILLION)
TABLE 288. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2032 (USD MILLION)
TABLE 289. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2032 (USD MILLION)
TABLE 290. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2032 (USD MILLION)
TABLE 291. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this MRI Guided Neurosurgical Ablation market report include:
  • Boston Scientific Corporation
  • Brown Neurosurgery
  • ClearPoint Neuro, Inc.
  • Cook Group Incorporated
  • Ginger Healthcare Private Ltd.
  • HCA International Limited
  • INSIGHTEC Ltd
  • Medtronic plc
  • Monteris Medical Corporation
  • Seattle Children’s Hospital
  • Siemens Healthineers AG
  • SternMed GmbH

Table Information

Report AttributeDetails
No. of Pages181
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 763.35 Million
Forecasted Market Value ( USD ) by 2032 $ 1410 Million
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

MRI-Guided Neurosurgical Ablation - Global Strategic Business Report - Product Image

MRI-Guided Neurosurgical Ablation - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
MRI Guided Neurosurgical Ablation Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

MRI Guided Neurosurgical Ablation Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 83 Pages
  • Global
From
Stereotactic System for Neurological Intervention Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Stereotactic System for Neurological Intervention Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 94 Pages
  • Global
From
Functional Neurosurgery and Neuromodulation - Product Image

Functional Neurosurgery and Neuromodulation

  • Book
Magnetic Resonance Imaging (MRI) Guided and Focused Ultrasound Devices Market Report 2025 - Product Image

Magnetic Resonance Imaging (MRI) Guided and Focused Ultrasound Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the MRI Guided Neurosurgical Ablation Market

MRI Guided Neurosurgical Ablation is a minimally invasive procedure used to treat neurological disorders. It involves the use of MRI imaging to guide the placement of a probe into the brain, which then delivers energy to the targeted area to destroy or ablate the tissue. This procedure is used to treat a variety of neurological conditions, including epilepsy, Parkinson's disease, and brain tumors. It is also used to treat chronic pain and other neurological disorders. MRI Guided Neurosurgical Ablation is a relatively new procedure, but it is becoming increasingly popular due to its minimally invasive nature and its ability to provide precise targeting of the affected area. It is also less expensive than traditional open surgery and has fewer risks associated with it. Some of the companies in the MRI Guided Neurosurgical Ablation market include Medtronic, Stryker, Brainlab, and Elekta. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.